Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Director acquired 17,950 shares (grant or award)
  3. 4 Grant or award Director acquired 17,950 shares (grant or award)
  4. 4 Grant or award Director acquired 17,950 shares (grant or award)
  5. 4 Grant or award Director acquired 17,950 shares (grant or award)
  6. 4 Grant or award Director acquired 17,950 shares (grant or award)
  7. 4 Grant or award Director acquired 17,950 shares (grant or award)
  8. 4 Option exercise EVP, Chief Financial Officer acquired 3,874 shares (option exercise)
  9. 4 Option exercise EVP, Chief Development Officer acquired 3,874 shares (option exercise)
  10. 4 Option exercise Chief Executive Officer acquired 13,797 shares (option exercise)
  11. 4 Grant or award Director acquired 37,879 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Option exercise EVP, Chief Financial Officer acquired 3,874 shares (option exercise)
  14. 4 Option exercise EVP, Chief Development Officer acquired 3,874 shares (option exercise)
  15. 4 Option exercise Chief Executive Officer acquired 13,797 shares (option exercise)
  16. 4 Option exercise Chief Executive Officer acquired 13,797 shares (option exercise)
  17. 4 Option exercise EVP, Chief Development Officer acquired 3,875 shares (option exercise)
  18. 4 Option exercise EVP, Chief Financial Officer acquired 3,875 shares (option exercise)
  19. 4 Option exercise EVP, Chief Financial Officer acquired 12,500 shares (option exercise)
  20. 4 Option exercise EVP, Chief Development Officer acquired 12,500 shares (option exercise)

Page 5 of 30 · 585 filings